166 related articles for article (PubMed ID: 12528761)
1. Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin.
Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
J Intern Med; 2002 Nov; 252(5):430-9. PubMed ID: 12528761
[TBL] [Abstract][Full Text] [Related]
2. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
J Cardiovasc Pharmacol; 2003 Dec; 42(6):719-26. PubMed ID: 14639093
[TBL] [Abstract][Full Text] [Related]
4. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE
Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810
[TBL] [Abstract][Full Text] [Related]
5. Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry.
Paolisso G; Tagliamonte MR; Galderisi M; Zito GA; D'Errico A; Marfella R; Carella C; de Divitiis O; Varricchio M
Am J Hypertens; 2001 Feb; 14(2):114-20. PubMed ID: 11243301
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
Kamide K; Rakugi H; Higaki J; Okamura A; Nagai M; Moriguchi K; Ohishi M; Satoh N; Tuck ML; Ogihara T
Am J Hypertens; 2002 Jan; 15(1 Pt 1):66-71. PubMed ID: 11824863
[TBL] [Abstract][Full Text] [Related]
7. Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.
Catena C; Verheyen ND; Url-Michitsch M; Kraigher-Krainer E; Colussi G; Pilz S; Tomaschitz A; Pieske B; Sechi LA
Am J Hypertens; 2016 Mar; 29(3):303-10. PubMed ID: 26163660
[TBL] [Abstract][Full Text] [Related]
8. Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years.
Strand AH; Gudmundsdottir H; Os I; Smith G; Westheim AS; Bjørnerheim R; Kjeldsen SE
J Hypertens; 2006 May; 24(5):905-13. PubMed ID: 16612253
[TBL] [Abstract][Full Text] [Related]
9. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.
Schunkert H; Hense HW; Muscholl M; Luchner A; Kürzinger S; Danser AH; Riegger GA
Heart; 1997 Jan; 77(1):24-31. PubMed ID: 9038690
[TBL] [Abstract][Full Text] [Related]
10. Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy.
Malmqvist K; Wallén HN; Held C; Kahan T
J Hypertens; 2002 Aug; 20(8):1563-9. PubMed ID: 12172318
[TBL] [Abstract][Full Text] [Related]
11. Differing roles of body mass and the renin-angiotensin system in mediating the hypertension syndrome.
Weber MA; Smith DH; Neutel JM
Am J Nephrol; 2000; 20(3):169-74. PubMed ID: 10878396
[TBL] [Abstract][Full Text] [Related]
12. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
[TBL] [Abstract][Full Text] [Related]
13. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
[TBL] [Abstract][Full Text] [Related]
14. Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension.
Gregori M; Tocci G; Giammarioli B; Befani A; Ciavarella GM; Ferrucci A; Paneni F
Can J Cardiol; 2014 Feb; 30(2):188-94. PubMed ID: 24461920
[TBL] [Abstract][Full Text] [Related]
15. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men.
Sundström J; Lind L; Nyström N; Zethelius B; Andrén B; Hales CN; Lithell HO
Circulation; 2000 Jun; 101(22):2595-600. PubMed ID: 10840010
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
18. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension.
Duprez DA; Bauwens FR; De Buyzere ML; De Backer TL; Kaufman JM; Van Hoecke J; Vermeulen A; Clement DL
Am J Cardiol; 1993 Jan; 71(3):17A-20A. PubMed ID: 8421999
[TBL] [Abstract][Full Text] [Related]
19. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
20. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
